Azienda Sociosanitaria 3

Clinical trial activity at this hospital in Genoa is strongly centered on cancer research, especially non-small cell lung cancer, small cell lung cancer, and bladder cancer. The studies are focused on testing new treatment options, comparing them with standard care, and improving outcomes for people with advanced or high-risk disease.

• Adjuvant treatment approaches for completely resected non-small cell lung cancer
• New therapies for advanced and metastatic lung cancer, including KRAS G12C-mutated disease
• Treatment strategies for relapsed small cell lung cancer
• Therapy evaluation in high-risk non-muscle-invasive bladder cancer with FGFR alterations

Overall, the research here aims to refine oncology care by assessing whether emerging medicines can better control disease, delay progression, and improve survival.

A major part of the research portfolio addresses respiratory tract diseases, with an emphasis on different forms of lung cancer. These studies are designed to evaluate how well new combinations and maintenance approaches work in patients whose disease has returned, spread, or required earlier treatment.

• Studies in advanced non-small cell lung cancer and metastatic non-small cell lung cancer
• Research in advanced/metastatic non-squamous NSCLC
• Comparisons of new immunotherapy-based and chemotherapy-based treatment options
• Investigations aimed at improving overall survival and progression-free survival

The work at this site reflects a strong effort to improve treatment effectiveness in thoracic oncology while helping identify better options for patients with difficult-to-treat respiratory cancers.

Alongside cancer studies, the site also contributes to health care and public health research through a smaller trial focused on symptom relief in non-streptococcal pharyngotonsillitis. This study looks at how well a commonly used lozenge can reduce pain in children, supporting better everyday treatment of an acute throat condition.

• Evaluation of pain relief in pediatric pharyngotonsillitis
• Assessment of a marketed treatment for symptom improvement
• Research focused on practical public health care in a common infection-related condition

This adds a patient-centered dimension to the research portfolio at SSD Oncologia PO Villa Scassi, complementing its broader focus on complex oncology trials.